Lumeon, the leader in Care Pathway Management (CPM), today announced that it has appointed two industry veterans to strengthen its position in the United States: Mark Clermont as chief financial officer (CFO) and Carl Schramm as chairman of the board. The appointments follow a number of recent customer wins and market traction, including securing U.S. customer, Keck Medicine of USC, and earning industry recognition of its CPM platform in the American Business Awards.
In his role as CFO, Mr. Clermont will oversee the alignment of Lumeon’s business and finance strategies to optimize for rapid growth. Prior to joining Lumeon, he served as president of Provant Health for three years until the company’s acquisition in Q4 2018. Clermont brings over ten years of experience serving as CFO for healthcare organizations, including UpToDate, Inc. and its acquiring company Wolters Kluwer Health. His deep experience and understanding of healthcare, along with his financial acumen and proven track record for company growth, positions Lumeon to capitalize on its recent momentum in the U.S.
“The U.S. healthcare market is shifting to value-based care, bringing the patient to the forefront,” said Clermont. “Consumers and providers alike expect more from the care system today and need tools that can keep up with this demand. Lumeon is playing a critical role during this tide change by providing a system of engagement for all parties to work together and improve care, and I couldn’t be more excited to join the company at such a pivotal time.”
Dr. Schramm, professor at Syracuse University and former president of the Ewing Marion Kauffman Foundation, joins Lumeon’s board of directors as chairman, where he will manage the board and support the company’s executive team in strategy development and execution. He carries a wealth of knowledge in U.S. healthcare operations and significant experience in building and scaling businesses successfully in the region. Schramm founded the nation’s first healthcare finance research center at The Johns Hopkins University, in addition to founding five other companies and serving in major corporate roles across numerous industries. Through his variety and depth of experience in healthcare, business, public policy, and academia, he is recognized as a respected thought-leader in healthcare finance, regulation, and insurance.
“The transition to a pay-for-performance healthcare market is applying pressure on hospitals and doctors to deliver more and better care, at a lower cost,” said Schramm. “Lumeon anticipated this moment in the U.S. and is seizing its first-mover advantage with software that allows hospitals to reduce unwarranted variation in financial and clinical outcomes – for which providers are increasingly being held directly accountable. The company is on the cusp of significant growth in the U.S. and I am delighted to bring my experience to the table to support that.”
“Mark and Carl both bring to Lumeon a deep understanding not only of U.S. healthcare but also extraordinary business experience,” said Robbie Hughes, founder, and CEO of Lumeon. “As the company continues to build on its recent momentum since entering the U.S. market, their expertise and leadership will help drive further growth. The addition of these two seasoned authorities in the industry demonstrates what an exciting time this is for Lumeon.”
Lumeon provides Care Pathway Management (CPM) solutions for healthcare organizations. Its industry leading platform combines evidence-based pathways with deep operational expertise to deliver better care at lower cost.
A patient-first approach to pathway design, orchestration and automation ensures healthcare provider resources are optimized to deliver superior outcomes at less cost, achieving the goals of new reimbursement models.
Progressive health systems in the USA and Europe have deployed Lumeon’s multi-award winning platform across more than 2,000 care locations.